Contribution of epigenetics in diabetic retinopathy
Authors:
Open Access
- 29 May 2015
- journal article
- review article
- Published by Springer Nature in Science China Life Sciences
- Vol. 58 (6) , 556-563
Abstract
Diabetes has become the epidemic of the 21st century, and with over 90% patients with diabetes becoming at a risk of developing retinopathy, diabetic retinopathy has emerged as a major public health concern. In spite of cutting edge research in the field, how retina and its vasculature are damaged by the diabetic milieu remains ambiguous. The environmental factors, life style or disease process can also bring in modifications in the DNA, and these epigenetic modifications either silence or activate a gene without altering the DNA sequence. Diabetic environment up- or downregulates a number of genes in the retina, and emerging research has shown that it also facilitates epigenetic modifications. In the pathogenesis of diabetic retinopathy, the genes associated with important enzymes (e.g., mitochondrial superoxide dismutase, matrix metalloproteinase-9 and thioredoxin interacting protein) and transcriptional factors are epigenetically modified, the enzymes responsible for these epigenetic modifications are either activated or inhibited, and the levels of microRNAs are altered. With epigenetic modifications taking an important place in diabetic retinopathy, it is now becoming critical to evaluate these modifications, and understand their impact on this slow progressing blinding disease.Keywords
This publication has 90 references indexed in Scilit:
- Experimental strategies for microRNA target identificationNucleic Acids Research, 2011
- Histone Demethylase LSD1 Regulates AdipogenesisJournal of Biological Chemistry, 2010
- Diabetic retinopathyThe Lancet, 2010
- Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenonJournal of Cellular Biochemistry, 2010
- Epigenetic factors in aging and longevityPflügers Archiv - European Journal of Physiology, 2009
- BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancerCarcinogenesis, 2009
- Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetesProceedings of the National Academy of Sciences, 2008
- Active and Repressive Chromatin Are Interspersed without Spreading in an Imprinted Gene Cluster in the Mammalian GenomeMolecular Cell, 2007
- Sirtuin activators mimic caloric restriction and delay ageing in metazoansNature, 2004
- Killing the messenger: short RNAs that silence gene expressionNature Reviews Molecular Cell Biology, 2003